Arkolith/Insider Trading/ALXO/Form 4

Lettmann Jason

CHIEF EXECUTIVE OFFICER, DirectorALX ONCOLOGY HOLDINGS INC (ALXO) · full profile →Form 4 · filed Sep 18, 2025
Net Buying
Open-Market Buys
$99K
Open-Market Sells
$0
Net Open-Market Flow
$99K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2025Buy(P)71K$1.08$77K305K
Sep 16, 2025Buy(P)21K$1.07$23K234K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-207432) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML